BioSpace News Archive

CRB, an international leader in sustainable engineering, architecture, construction and consulting solutions to the food and beverage and life sciences industries, today announced the election of four new members to its Board of Directors.

Paradigm4 has launched its REVEALTM: Multi-Omics app, allowing researchers to undertake advanced, cross-study analyses and enable quick searches for genes and proteins across all integrated public reference and proprietary datasets.

ERYTECH Pharma (Nasdaq & Euronext: ERYP),today announced its intention to move forward towards the submission of a BLA to the US Food and Drug Administration (FDA)for eryaspase in hypersensitive acute lymphoblastic leukemia (ALL) patientsfollowing feedback from the agency in a pre-BLA meeting.

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a joint agreement with Blackrock Neurotech to develop an automated surgical solution for implanting Brain Computer Interfaces (BCIs) into patients with a wide range of neurological disorders including paralysis, ALS, blindness, hearing loss and more.

Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, July 28, 2021 to discuss the company’s second quarter 2021 financial results.

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report second quarter 2021 financial results on Wednesday, August 4, 2021, after the U.S. financial markets close.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2021, after the market close on Wednesday, July 28, 2021.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its second quarter 2021 financial results after the market closes on Wednesday, August 4, 2021.

Kane Biotech Inc., announces that it has cancelled 8,470,555 stock options of the Company of various directors, officers, employees and consultants of the Company.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2021 on Wednesday, July 28, 2021, after the market closes.